In today’s recent session, 2.49 million shares of the CVS Health Corp (NYSE:CVS) have been traded, and its beta is 0.54. Most recently the company’s share price was $63.04, and it changed around $1.7 or 2.77% from the last close, which brings the market valuation of the company to $79.74B. CVS at last check was trading at a discount to its 52-week high of $72.51, offering almost -15.02% off that amount. The share price’s 52-week low was $43.56, which indicates that the recent value has risen by an impressive 30.9% since then. We note from CVS Health Corp’s average daily trading volume that its 10-day average is 10.13 million shares, with the 3-month average coming to 10.29 million.
CVS Health Corp stock received a consensus recommendation rating of Buy, based on a mean score of 1.72. If we narrow it down even further, the data shows that 0 out of 29 analysts rate the stock as a Sell; another 7 rate it as Overweight. Among the rest, 9 recommended CVS as a Hold, whereas 13 deemed it a Buy, and 0 rated it as Underweight.
CVS Health Corp (NYSE:CVS) trade information
Instantly CVS has been showing a green trend so far today with a performance of 2.77% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 63.24 on recent trading dayincreased the stock’s daily price by 0.32%. The company’s shares are currently up 40.43% year-to-date, but still down -1.10% over the last five days. On the other hand, CVS Health Corp (NYSE:CVS) is -2.92% down in the 30-day period. We can see from the shorts that 15.9 million shares have been sold at a short interest cover period of 1.41 day(s).
The consensus price target as assigned by Wall Street analysts is $71.5, which translates to bulls needing to increase their stock price by 11.83% from its current value. Analyst projections state that CVS is forecast to be at a low of $66 and a high of $77.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -6.37%. CVS Health Corp earnings are expected to increase by 13.02% in 2025, but the outlook is positive 13.79% per year for the next five years.
CVS Dividends
CVS Health Corp’s next quarterly earnings report is expected to be released on 2025-Apr-30. The annual dividend yield of the stock is 4.22 percent and its annual dividend per share was 2.66. It is important to note, however, that the 4.22% dividend yield ratio should be regarded as a guide only, as many other factors should be taken into consideration before making any investment decision. The average dividend yield for the past five years averaged 3.1 per year.
CVS Health Corp (NYSE:CVS)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.07% of CVS Health Corp shares, and 87.56% of them are in the hands of institutional investors. The stock currently has a share float of 88.50%. CVS Health Corp stock is held by 2292.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 9.2635% of the shares, which is about 116.35 million shares worth $6.87 billion.
BLACKROCK INC., with 7.9738% or 100.15 million shares worth $5.91 billion as of 2024-06-30, holds the second largest percentage of outstanding shares.
Dodge & Cox Funds-Dodge & Cox Stock Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 46.04 shares worth $2.91 billion, making up 3.64% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 39.44 shares worth around $2.49 billion, which represents about 3.12% of the total shares outstanding.
